GLIX1 Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
GLIX1 General Information
Description
Provider of drug development services intended to treat glioblastoma and other cancers.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
- Oslo
- Norway
Primary Industry
Drug Discovery
Corporate Office
- Oslo
- Norway
GLIX1 Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GLIX1 Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
GLIX1 FAQs
-
When was GLIX1 founded?
GLIX1 was founded in 2025.
-
Where is GLIX1 headquartered?
GLIX1 is headquartered in Oslo, Norway.
-
What industry is GLIX1 in?
GLIX1’s primary industry is Drug Discovery.
-
Is GLIX1 a private or public company?
GLIX1 is a Private company.
-
What is GLIX1’s current revenue?
The current revenue for GLIX1 is .
-
Who are GLIX1’s investors?
BioLineRx and Hemispherian have invested in GLIX1.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process